iSpecimen (ISPC) stock forecast for 2024. Forecast tables and graphs.







Buy or Sell NVDA stocks? (NVDA) forecasting

Nvidia: Still Charging Ahead

December 1, 2024
A Comprehensive Guide to RoadRunner Auto Transport Services

October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services

If you want to ship your car from one city to another, why not hire the experts to do everything for you? They…
Mastering Trading Indicators: Your Essential Toolkit For Success

October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success

Often investors struggle to identify profitable trades consistently. Trading indicators provide essential data to guide trading decisions. This article explains key indicators and…
Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…

iSpecimen (ISPC) stock forecast for 2024

Updated: November 30, 2024 (06:16)

Sector: Healthcare

The share price of iSpecimen Inc. (ISPC) now

What analysts predict: $3
52-week High/Low: $12.2 / $3.41

50/200 Day Moving Average: $4.633 / $5.8

This figure corresponds to the Average Price over the previous 50/200 days. For iSpecimen stocks, the 50-day moving average is the resistance level today.

For iSpecimen stocks, the 200-day moving average is the resistance level today.

Are you interested in iSpecimen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the iSpecimen stock price in 2024. How much will one iSpecimen share be worth in 2024? Is it worth taking profit / loss on ISPC stock now or waiting? What are analysts' forecasts for iSpecimen stock?

We forecast iSpecimen stock performance using neural networks based on historical data on ISPC stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

iSpecimen Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for iSpecimen analysts is $3. Today 200 Day Moving Average is the resistance level (5.8 $). 50 Day Moving Average is the resistance level (4.633 $).




Historical and forecast chart of iSpecimen Inc. stock

The chart below shows the historical price of iSpecimen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ISPC stock price can be found in the table below.


iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.

Trending Themes in the Healthcare Sector

iSpecimen (ISPC) Forecast for 2024

Month Target Pes. Opt. Vol., %
Dec 4.43 4.18 4.78 12.64 %

iSpecimen information and performance

iSpecimen Address

450 BEDFORD STREET, SUITE 1010, LEXINGTON, MA, US

Market Capitalization: 4 062 300 $

Market capitalization of the iSpecimen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ISPC shares in the company outstanding by the market price of one share.

EBITDA: -9 505 241 $

EBITDA of iSpecimen is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -18.12

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.042
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 0.337

Enterprise Value (EV) /Revenue

EV To EBITDA: 0.429

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 962640

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

iSpecimen price target for 2024 by month


Target values for the price of one iSpecimen share for Dec 2024.

The weighted average target price per iSpecimen share in Dec 2024 is: 4.43.
In Dec, the Positive dynamics for iSpecimen Inc. shares will prevail with possible monthly volatility of 12.645% volatility is expected.
Pessimistic target level: 4.18
Optimistic target level: 4.78



Related stocks from Healthcare sector


Disclaimer: